The PBS NewsHour Weekend reporting team is gathering stories about the high cost of prescription drugs and patients’ experiences at the pharmacy.
By Megan Thompson
A new study comes amid ongoing concern that consumers do not read or have difficulty reading prescription drug risk information.
By Ed Silverman, STAT
An overwhelming majority of Americans favor government action to restrain prescription drug prices, according to a poll released Thursday.
By Jordan Rau, Kaiser Health News
Retail clinics, long seen as an antidote to more expensive doctor offices and emergency rooms, may actually boost medical spending by leading consumers to get more care, a new study shows.
By Chad Terhune, Kaiser Health News
By Philip Moeller
Many Medicare drug plans – both Part D and plans that are part of Medicare Advantage policies – offer very low premiums to get you in the door. But they have ways of shifting the costs back on to Medicare…
By Ricardo Alonso-Zaldivar, Associated Press
WASHINGTON — Call it drugs for the departed: Medicare's prescription program kept paying for costly medications even after patients were dead. The problem was traced back to a head-scratching bureaucratic rule that's now getting a second look.
By Making Sen$e Editor
We all know generics are cheaper. But how much cheaper? Economists find a 38 to 48 percent decline in the prices of physician-administered drugs after the drugs' patents have expired. The decline is slightly lower for oral drugs.
Researchers at George Washington University have found a significant increase in prescriptions for opioidsopioid analgesics, such as Percocet, Vicodin, oxycodone and Dilaudid, despite only a modest increase in visits for painful conditions.
NewsHour Weekend's Megan Thompson reports on the surprising disparity in pricing for generic drugs. Generics, generally thought to be cheap, can actually vary widely in price from pharmacy to pharmacy, causing some to skip medications altogether.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.